Changes to New York’s Rebate Programs

Changes to New York’s Rebate Programs

Manufacturers are often intimidated when directed by New York to participate in Medicaid, due to the uniqueness of their programs. We aim to eliminate confusion in navigating these processes to resolution. In this blog post, we’ll walk you through a summary of the most recent changes to the New York Medicaid programs.

Read More
 State Medicaid Programs Retake Pharmacy Controls

State Medicaid Programs Retake Pharmacy Controls

State Medicaid programs’ relationships with managed care organizations that serve Medicaid recipients continue to evolve. Just when it appears that trends are slowing or stabilizing, a new method is introduced. The latest development could overlap existing state controls to bring even more pharmacy control back to state management.

Read More
 Reimbursement Challenges with High-Cost Inpatient Drugs

Reimbursement Challenges with High-Cost Inpatient Drugs

The management and reimbursement of inpatient drug costs in Medicaid programs are pivotal topics, especially with the proliferation of high-cost therapies. The emergence of expensive inpatient drugs, such as cell and gene therapies, have challenged Diagnosis Related Groups (DRGs), the traditional bundled payment system used by hospitals.

Read More
 Cell and Gene Therapy Access Model from CMS Offers New Perspective to Value-Based Purchasing Agreements

Cell and Gene Therapy Access Model from CMS Offers New Perspective to Value-Based Purchasing Agreements

Will the involvement of a federal agency change the progress of value-based purchasing in the Medicaid program? The 2024 calendar year will provide insight into whether this intervention will expand opportunities for states and manufacturers.

Read More
 Florida Senate Passes Resolution Recognizing February 15, 2024, as Angelman Syndrome Awareness Day

Florida Senate Passes Resolution Recognizing February 15, 2024, as Angelman Syndrome Awareness Day

Artia Solutions and The Garner Group are proud to support the recognition of February 15, 2024, as Angelman Syndrome Awareness Day in the state of Florida through SR 1802, sponsored by Senator Alexis Calatayud, R-Miami Dade.

Read More
 AMP Cap Removal: What Drug Manufacturers Need to Know in 2024 and Beyond

AMP Cap Removal: What Drug Manufacturers Need to Know in 2024 and Beyond

Who will have the happier new year in 2024 – pharmaceutical manufacturers or state Medicaid programs? See what considerations will be made by each side over the next six-to-eight months to preserve finances while serving Medicaid recipients.

Read More